Medicinal Chemistry

The identification, synthesis, and development of drugs for therapeutic use requires medicinal chemistry. For commercial and government clients, SRI Biosciences chemists perform complex and multistep drug synthesis procedures using expertise in radiochemistry services, chiral synthesis, bioisostere incorporation, process design, and process optimization.

SRI researchers operate in modern laboratories equipped with computer-assisted drug design instrumentation and parallel synthesis equipment. Services include:

  • Custom drug synthesis, featuring ideal, timely, and cost-effective outsourcing options

  • Custom isotope labeling, for isotopically labeled compounds of high purity and high isotopic enrichment. SRI offers specific labeling patterns for complex molecules and drugs used in metabolism and biochemical studies.

  • Parallel synthesis, for the design and synthesis of small molecule, peptide, and peptidomimetic libraries using both solution and solid-phase synthesis approaches. SRI works with clients to generate moderate-sized focused libraries.

Complex targets we have synthesized include

  • Artemesin antimalarials

  • Benzotriazine anticancer agents

  • Carbapenem antibiotics

  • Steroidal HRT and anticancer agents

  • Peptidomimetic antihypertensives

  • Catechin chemopreventives

  • Methotrexate anticancer agents

Projects

scientist working at a computer

SRI has developed a promising new treatment for this cancer of the immune system that affects plasma cells in bone marrow.

scientist with a computer model of a molecular structure

SRI is identifying candidates for advanced therapies in multiple disease areas by developing compounds from synthetically optimized, natural dietary products.

monoclonal antibodies

Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.

a high-throughput fluorescence polarization assay

SRI is seeking new treatments for tuberculosis, a global health crisis.

a glowing blue neuron

SRI sleep researchers are working to discover and develop new treatments for narcoleptic patients.

scientist checking a batch of vaccines

SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.